Business Context and Reporting Period
Company: PHOTRONICS, INC.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended July 31, 1995
Business Overview: Photronics is a photomask manufacturer. The reporting period was significantly impacted by the acquisition of Hoya Micro Mask, Inc. ("Micro Mask") in December 1994 and Microphase Laboratories, Inc. ("Microphase") in June 1995, expanding operations to Sunnyvale, California, and Colorado Springs, Colorado.
Key Financial Metrics
| Metric (in thousands) | 9 Months Ended July 31, 1995 | 9 Months Ended July 31, 1994 | 3 Months Ended July 31, 1995 | 3 Months Ended July 31, 1994 |
|---|---|---|---|---|
| Net Sales | $89,067 | $58,811 | $32,854 | $21,313 |
| Cost of Sales | $54,854 | $37,799 | $20,015 | $13,096 |
| Gross Margin % | 38.4% | 35.7% | 39.1% | 38.6% |
| Operating Income | $15,957 | $9,896 | $5,173 | $3,875 |
| Net Income | $13,547 | $7,150 | $6,460 | $2,765 |
| Diluted EPS | $1.24 | $0.71 | $0.54 | $0.27 |
| Cash from Operations | $21,583 | $13,522 | - | - |
| Cash & Equivalents (End of Period) | $46,583 | $19,330 | - | - |
| Total Debt (Current + Long-term) | $1,881 | $962 | - | - |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 51.4% for the nine months ended July 31, 1995, driven by the inclusion of Micro Mask sales and increased shipments from existing facilities due to capacity expansion.
- Profitability: Net income nearly doubled (89.5% increase) for the nine-month period. Operating margins improved due to higher capacity utilization and a favorable mix of complex photomasks.
- Acquisition Impact: The Micro Mask acquisition contributed significantly to sales and operating expenses. The Microphase acquisition resulted in a one-time $1.5 million charge to R&D expenses.
- Non-Operating Income: Interest and other income surged to $5.7 million (nine months) compared to $575,000 in the prior year, primarily due to a $4.7 million net gain from the sale of an equity investment.
- Capital Structure: The company completed a public equity offering in April 1995, issuing 1.5 million shares for net proceeds of approximately $29.6 million. A 3-for-2 stock split was also effected in March 1995.
Guidance, Outlook, and Risks
- Outlook: Management anticipates fixed operating costs will increase due to continuing capacity expansion but expects to match these with continued sales increases.
- Capital Expenditures: As of July 31, 1995, the company had commitments of $49.0 million for additional property, plant, and equipment, including $11.3 million for a new facility in the Dallas area.
- Liquidity: The company believes current resources, including a new $10 million revolving credit facility and proceeds from the stock offering, are sufficient to meet cash requirements.
- Risks/Contingencies: The filing notes that proforma results of acquisitions are not necessarily indicative of future results. The company is subject to financial covenants under its new credit agreement.
Investor Verification Checklist
- Acquisition Integration: Verify the operational integration and revenue contribution of the Micro Mask and Microphase facilities against proforma estimates.
- Non-Recurring Gains: Assess the sustainability of earnings by excluding the $4.7 million gain on the sale of equity investments.
- Capital Commitments: Review the $49.0 million in outstanding commitments for new facilities and equipment to ensure adequate funding sources.
- Working Capital Trends: Monitor the significant increase in accounts receivable ($18.1M) and inventory ($5.3M) to ensure collection and turnover rates remain healthy.
- Stock Dilution: Confirm the impact of the recent 3-for-2 stock split and new share issuances on future per-share metrics.